Answers are grounded in this paper and cite their sources.
First in human phase I trials are an unaviodable gateway to the development of new anticancer therapies. The discovery of target therapies have significantly changed the process of clinical drug development.This short review will focus on the main features including knowledge of biological aspects, methodology and adequacy of design and of performance of early clinical studies.
No takes yet. Share an insight, caveat, or question.
Maur et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: